S H Kelkar & Company Ltd
S H Kelkar & Company Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #58 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
S H Kelkar & Company Ltd Q3 FY26 key numbers
- Revenue
- Additional capacity in Southeast Asia (3,600 tons) is expected to add 5-7 million in turnover sales.
As stated in S H Kelkar & Company Ltd's Q3 FY26 earnings call transcript · published 14 Jun 2026. Reported figures, not investment advice.
The short version
The company targets a 12% year-on-year CAGR growth with FY '24-'25 as the base year. Flavours EBIT margins expected to remain steady at 20%-22% through FY27-FY28.
From S H Kelkar & Company Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company targets a 12% year-on-year CAGR growth with FY '24-'25 as the base year.
- Additional capacity in Southeast Asia (3,600 tons) is expected to add 5-7 million in turnover sales.
- European capacity catering to €50 million is about 90% utilized; plans to increase capacity by 1.5x soon to support aggressive growth in Europe.
- India has current capacity of ~20,000 tons with expansions adding 9,000 tons in Q1 next year and another 15,000 tons thereafter, indicating strong growth headroom.
- Strong double-digit growth is seen in Middle East, Africa, Central Asia, and Southeast Asia markets.
- U.S. market initiatives are beginning to generate orders, with business expected to grow from Q4 this year and into FY '29.
2 more points from S H Kelkar & Company Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what S H Kelkar & Company Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Europe: Committed EUR 7-8 million capex, mostly done; expects another EUR 2-3 million outflow in next 6-12 months. New factory expected operational by Q4 FY26, expanding capacity 1.5x from current 90% utilization.
- India: Capex of Rs. 70-80 crore over next 12-18 months focused on rebuilding facilities (Vashivali and Vanavate) post-fire and new expansions; adding 9,000 tons capacity in Q1 FY27 and further 15,000 tons later.
- U.S.: Investment primarily opex for leased manufacturing and creative development centres (~$1.5-2 million invested); expecting $2-2.5 million business by end of next year. Minimal capex as manufacturing is operational lease-based.
2 more points from S H Kelkar & Company Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what S H Kelkar & Company Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- It mentions that the U.S. Creative Development Centre secured its first customer order, with execution expected from Q4 this year to Q1 next year.
- European business showed 3% YoY growth in euro terms this quarter, indicating healthy demand.
- The company is seeing green shoots and new business opportunities in the U.S., Europe, U.K., Middle East, and Southeast Asia.
- There is some softness in demand in India post-GST changes, but the company expects sales momentum to recover shortly.
2 more points from S H Kelkar & Company Ltd's call on order book
Create a free account to keep reading this call
S H Kelkar & Company Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹650 Cr, net profit ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What S H Kelkar & Co.'s management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
Others in Chemicals & Petrochemicals this season
- Neochem Bio (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chem. (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- IVP (Q3 FY26)
Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector
- Gujarat Alkalies (Q3 FY26)
3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
S H Kelkar & Company Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were S H Kelkar & Company Ltd Q3 FY26 results?
The company targets a 12% year-on-year CAGR growth with FY '24-'25 as the base year. Flavours EBIT margins expected to remain steady at 20%-22% through FY27-FY28.
What is S H Kelkar & Company Ltd share price analysis?
S H Kelkar & Company Ltd currently shows a neutral. The stock trades at a P/E of 50.0 with a market cap of ₹2,363 Cr. Investors should review the full earnings analysis for detailed insights.
Is S H Kelkar & Company Ltd planning capital expenditure?
Europe: Committed EUR 7-8 million capex, mostly done; expects another EUR 2-3 million outflow in next 6-12 months.
Keep S H Kelkar & Company Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
